Cargando…

Inhibition Ability of Natural Compounds on Receptor-Binding Domain of SARS-CoV2: An In Silico Approach

The lack of medication to treat COVID-19 is still an obstacle that needs to be addressed by all possible scientific approaches. It is essential to design newer drugs with varied approaches. A receptor-binding domain (RBD) is a key part of SARS-CoV-2 virus, located on its surface, that allows it to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Nedyalkova, Miroslava, Vasighi, Mahdi, Sappati, Subrahmanyam, Kumar, Anmol, Madurga, Sergio, Simeonov, Vasil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704597/
https://www.ncbi.nlm.nih.gov/pubmed/34959727
http://dx.doi.org/10.3390/ph14121328
_version_ 1784621744860954624
author Nedyalkova, Miroslava
Vasighi, Mahdi
Sappati, Subrahmanyam
Kumar, Anmol
Madurga, Sergio
Simeonov, Vasil
author_facet Nedyalkova, Miroslava
Vasighi, Mahdi
Sappati, Subrahmanyam
Kumar, Anmol
Madurga, Sergio
Simeonov, Vasil
author_sort Nedyalkova, Miroslava
collection PubMed
description The lack of medication to treat COVID-19 is still an obstacle that needs to be addressed by all possible scientific approaches. It is essential to design newer drugs with varied approaches. A receptor-binding domain (RBD) is a key part of SARS-CoV-2 virus, located on its surface, that allows it to dock to ACE2 receptors present on human cells, which is followed by admission of virus into cells, and thus infection is triggered. Specific receptor-binding domains on the spike protein play a pivotal role in binding to the receptor. In this regard, the in silico method plays an important role, as it is more rapid and cost effective than the trial and error methods using experimental studies. A combination of virtual screening, molecular docking, molecular simulations and machine learning techniques are applied on a library of natural compounds to identify ligands that show significant binding affinity at the hydrophobic pocket of the RBD. A list of ligands with high binding affinity was obtained using molecular docking and molecular dynamics (MD) simulations for protein–ligand complexes. Machine learning (ML) classification schemes have been applied to obtain features of ligands and important descriptors, which help in identification of better binding ligands. A plethora of descriptors were used for training the self-organizing map algorithm. The model brings out descriptors important for protein–ligand interactions.
format Online
Article
Text
id pubmed-8704597
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87045972021-12-25 Inhibition Ability of Natural Compounds on Receptor-Binding Domain of SARS-CoV2: An In Silico Approach Nedyalkova, Miroslava Vasighi, Mahdi Sappati, Subrahmanyam Kumar, Anmol Madurga, Sergio Simeonov, Vasil Pharmaceuticals (Basel) Article The lack of medication to treat COVID-19 is still an obstacle that needs to be addressed by all possible scientific approaches. It is essential to design newer drugs with varied approaches. A receptor-binding domain (RBD) is a key part of SARS-CoV-2 virus, located on its surface, that allows it to dock to ACE2 receptors present on human cells, which is followed by admission of virus into cells, and thus infection is triggered. Specific receptor-binding domains on the spike protein play a pivotal role in binding to the receptor. In this regard, the in silico method plays an important role, as it is more rapid and cost effective than the trial and error methods using experimental studies. A combination of virtual screening, molecular docking, molecular simulations and machine learning techniques are applied on a library of natural compounds to identify ligands that show significant binding affinity at the hydrophobic pocket of the RBD. A list of ligands with high binding affinity was obtained using molecular docking and molecular dynamics (MD) simulations for protein–ligand complexes. Machine learning (ML) classification schemes have been applied to obtain features of ligands and important descriptors, which help in identification of better binding ligands. A plethora of descriptors were used for training the self-organizing map algorithm. The model brings out descriptors important for protein–ligand interactions. MDPI 2021-12-18 /pmc/articles/PMC8704597/ /pubmed/34959727 http://dx.doi.org/10.3390/ph14121328 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nedyalkova, Miroslava
Vasighi, Mahdi
Sappati, Subrahmanyam
Kumar, Anmol
Madurga, Sergio
Simeonov, Vasil
Inhibition Ability of Natural Compounds on Receptor-Binding Domain of SARS-CoV2: An In Silico Approach
title Inhibition Ability of Natural Compounds on Receptor-Binding Domain of SARS-CoV2: An In Silico Approach
title_full Inhibition Ability of Natural Compounds on Receptor-Binding Domain of SARS-CoV2: An In Silico Approach
title_fullStr Inhibition Ability of Natural Compounds on Receptor-Binding Domain of SARS-CoV2: An In Silico Approach
title_full_unstemmed Inhibition Ability of Natural Compounds on Receptor-Binding Domain of SARS-CoV2: An In Silico Approach
title_short Inhibition Ability of Natural Compounds on Receptor-Binding Domain of SARS-CoV2: An In Silico Approach
title_sort inhibition ability of natural compounds on receptor-binding domain of sars-cov2: an in silico approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704597/
https://www.ncbi.nlm.nih.gov/pubmed/34959727
http://dx.doi.org/10.3390/ph14121328
work_keys_str_mv AT nedyalkovamiroslava inhibitionabilityofnaturalcompoundsonreceptorbindingdomainofsarscov2aninsilicoapproach
AT vasighimahdi inhibitionabilityofnaturalcompoundsonreceptorbindingdomainofsarscov2aninsilicoapproach
AT sappatisubrahmanyam inhibitionabilityofnaturalcompoundsonreceptorbindingdomainofsarscov2aninsilicoapproach
AT kumaranmol inhibitionabilityofnaturalcompoundsonreceptorbindingdomainofsarscov2aninsilicoapproach
AT madurgasergio inhibitionabilityofnaturalcompoundsonreceptorbindingdomainofsarscov2aninsilicoapproach
AT simeonovvasil inhibitionabilityofnaturalcompoundsonreceptorbindingdomainofsarscov2aninsilicoapproach